Spirometry-Based Screening for Pulmonary Function Abnormalities in Dukuh Kupang: A Pilot Cross-Sectional Study
DOI:
https://doi.org/10.33096/03prn178Kata Kunci:
Community-based screening, pulmonary function impairment, spirometryAbstrak
Introduction: Pulmonary function abnormalities are often underrecognized in the community, particularly in their early stages. This pilot study aimed to describe spirometry findings in a community setting and examine their associations with age, sex, body mass index (BMI), and smoking history.
Methods: A pilot cross-sectional study was conducted among residents of Dukuh Kupang, Surabaya, during a community-based spirometry program. Fifty-eight participants were recruited consecutively. Variables included age group, sex, BMI category, smoking history, and spirometry results (normal, obstructive, restrictive, or mixed), which were further classified as normal versus abnormal. Data were obtained through structured interviews, anthropometric measurements, and spirometry testing. Associations were analyzed using the chi-square or Fisher–Freeman–Halton test, as appropriate.
Result: Abnormal spirometry findings were identified in 32 of 58 participants (55.2%). Obstructive patterns were found in 36.2%, restrictive patterns in 13.8%, and mixed patterns in 5.2%. Abnormal results were significantly associated with age (p < 0.001), sex (p < 0.001), smoking history (p < 0.001), and BMI category (p = 0.009).
Conclusion: This pilot community-based study identified a substantial proportion of pulmonary function abnormalities among residents of Dukuh Kupang, Surabaya. The findings support the potential value of spirometry as an early community-level tool for identifying pulmonary function abnormalities and informing targeted respiratory health strategies and follow-up planning.
Referensi
1. Alnoor SAM, Elhag OEY, Ali NMA, Yousif YOE, Mohamed AAE, Saad AHS, et al. Prevalence of chronic respiratory diseases diagnosed by pulmonary function testing: a cross-sectional study. Annals of Medicine & Surgery. 2025 Feb;87(2):477–86. doi:10.1097/MS9.0000000000002884
2. Kim SH, Han MK. Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD. Tuberc Respir Dis (Seoul). 2025 Jul 1;88(3):413–8. doi:10.4046/trd.2025.0009
3. Zhai Y, Zhu C, Zhu T, Song W, Tang Y, Jiang L, et al. Global, regional, and national burden of chronic respiratory diseases,1990–2021 and predictions to 2035: analysis of data from the global burden of disease study 2021. Ann Med. 2025 Dec 31;57(1). doi:10.1080/07853890.2025.2530225
4. Qaid EYA, Long I. Asthma unravelled: a comprehensive review of epidemiology, phenotypes, pathophysiology, and emerging therapies. The Egyptian Journal of Bronchology. 2025 Aug 1;19(1):82. doi:10.1186/s43168-025-00443-w
5. Cao Z, Tong X, He L, Luo Y, Huang K, Li W, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2021: results from the Global Burden of Disease Study 2021. BMJ Public Health. 2026 Jan 13;4(1):e002489. doi:10.1136/bmjph-2024-002489
6. Soetedjo FA, Kristijanto JA, Agusaputra H, Kusumaningtyas MJ. Peperomia pellucida Extract Ameliorates Secondhand Smoke Exposure-Induced Lung Fibrogenesis via Regulation of Matrix Metalloproteinase, Inflammatory, and Fibrotic Cytokines: A Pre-Clinical Study. Pharmaceutical Sciences Asia Pharm Sci Asia. 2024;51(3):223–32. doi:10.29090/psa.2024.03.24.AP0565
7. Kristijanto JAF, Zahiroh VN, Triadi A, Khamidah N, Soetedjo FA. Protective Effects of Peperomia pellucida Extract Against Secondhand Smoke-Induced Pulmonary Fibrosis via Antioxidant and Anti-inflammatory Pathways. Tropical Journal of Natural Product Research. 2025 Sep 30;9(9). doi:10.26538/tjnpr/v9i9.50
8. Musoddaq MA, Tjandrarini DH, Senewe FP, Letelay AM, Ashar H, Setyawati B, et al. Factors Associated with Smoking Cessation in Underdeveloped Areas of Indonesia. J Res Health Sci. 2026 Jan 1;26(1):e00671. doi:10.34172/jrhs.11518
9. Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(5):31. doi:10.4103/sja.SJA_543_18
10. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70–88. doi:10.1164/rccm.201908-1590ST
11. Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14–7. PubMed PMID: 24834239.
12. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. European Respiratory Journal. 2012 Dec;40(6):1324–43. doi:10.1183/09031936.00080312
13. Khamidah N, Anggraini Soetedjo F, Falerio Kristijanto JA, Siswoyo S. Hubungan Usia dan Jenis Kelamin dengan Tekanan Darah Serta Kadar Glukosa Darah pada Masyarakat di Desa Made Kota Surabaya. COMSERVA : Jurnal Penelitian dan Pengabdian Masyarakat. 2025 Jul 7;5(3):979–87. doi:10.59141/comserva.v5i3.3251
14. Kristijanto JAF, Soetedjo FA, Khamidah N, Siswoyo S. Deteksi Dini Hipertensi dan Hiperglikemia Berbasis Komunitas di Desa Made Kota Surabaya Sebagai Upaya Pencegahan Penyakit Tidak Menular. Blantika: Multidisciplinary Journal. 2025 Jul 28;3(8):1166–72. doi:10.57096/blantika.v3i8.394
15. Soetedjo FA, Arimbi MR, Khamidah N, Kristijanto JAF. Pembentukan “Pondok Paru Sehat” Sebagai Pusat Edukasi dan Deteksi Dini Penyakit Paru Obstruktif Kronis, Asma, dan Tuberkulosis di Kelurahan Dukuh Kupang Kota Surabaya. COMSERVA : Jurnal Penelitian dan Pengabdian Masyarakat. 2024 Jun 30;4(3):567–75. doi:10.59141/comserva.v4i3.1391
16. Soetedjo FA, Arimbi MR, Khamidah N, Kristijanto JAF. Optimalisasi “Pondok Paru Sehat” Kelurahan Dukuh Kupang Kota Surabaya Melalui Edukasi Peran Gizi Dalam Penyakit Paru Obstruktif Kronis (PPOK) Dan Pemeriksaan Fungsi Paru (Spirometry) Untuk Deteksi Dini PPOK. COMSERVA : Jurnal Penelitian dan Pengabdian Masyarakat. 2025 Aug 29;5(3). doi:10.59141/comserva.v5i3.3313
17. Doi K, Hirano T, Oishi K, Fukatsu-Chikumoto A, Ohteru Y, Hamada K, et al. Gender Difference in the Relationship between Extrapulmonary Factors and Reduced Lung Function in Early Adulthood. J Clin Med. 2024 Mar 19;13(6):1769. doi:10.3390/jcm13061769
18. Mustra Rakic J, Zeng S, Rohdin-Bibby L, Van Blarigan EL, Liu X, Ma S, et al. Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 2022;377–93. doi:10.15326/jcopdf.2022.0289
19. Lin CH, Cheng SL, Chen CZ, Chen CH, Lin SH, Wang HC. Current Progress of COPD Early Detection: Key Points and Novel Strategies. Int J Chron Obstruct Pulmon Dis. 2023 Jul;Volume 18:1511–24. doi:10.2147/COPD.S413969
20. Korsbæk N, Landt E, Dahl M. Second-Hand Smoke Exposure Associated with Risk of Respiratory Symptoms, Asthma, and COPD in 20,421 Adults from the General Population. J Asthma Allergy. 2021 Oct;Volume 14:1277–84. doi:10.2147/JAA.S328748
21. Resmi M, Dokter P, Indonesia P, Arifin PM, Faisal N, Agus Y, et al. Problems of Chronic Obstructive Pulmonary Disease (COPD) Among Workers. Jurnal Respirologi Indonesia. 2021 Jan 31;41(1):64–73. doi:10.36497/JRI.V41I1.148
22. Elsaidy WH, Alzahrani SA, Boodai SM. Exploring the correlation between body mass index and lung function test parameters: a cross-sectional analytical study. BMC Res Notes. 2024 Oct 24;17(1):320. doi:10.1186/s13104-024-06967-6
23. Alberto Neder J, Cortozi Berton D, E. O’Donnell D. Obesity: how pulmonary function tests may let us down. Jornal Brasileiro de Pneumologia. 2020 May 20;46(3):e20200116–e20200116. doi:10.36416/1806-3756/e20200116
24. Esam Mahmood S, A Alqahtani AT, Alghamdi BAA, Gazzan MA, A Alqahtani MY, Y Alfaifi NA, et al. Awareness of COPD and Its Risk Factors Among the Adult Population of the Aseer Region, Saudi Arabia. Int J Chron Obstruct Pulmon Dis. 2023 Jan;Volume 18:23–35. doi:10.2147/COPD.S378064
25. Krishnan JA. The Case for Case-Finding in Asthma and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2025 Nov 1;211(11):1982–3. doi:10.1164/rccm.202509-2272ED
